This article was first published in eHealth Law & policy , Volume: 3 Issue: 6, June 2016
CRISPR-Cas9 is a revolutionary gene editing technology that enables genomic modifications in a wide variety of organisms and tissues. Dr Sahar Shepperd, discusses the application of CRISPR-Cas9 in editing both human and non-human cells and the ethical issues surrounding such technologies, and provides an overview of the existing EU laws on gene editing.
To read the full article, please click HERE (subscription only).
Download PDF version HERE.